Association of cognitive dysfunction with hippocampal atrophy in elderly Japanese people with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 94, Issue 2, 2011, Pages 180-185

  Hayashi, Kumi ^a   Kurioka, Soichi ^a   Yamaguchi, Toru ^a   Morita, Miwa ^a   Kanazawa, Ippei ^a   Takase, Hirofumi ^a   Wada, Akihiko ^a   Kitagaki, Hajime ^a   Nagai, Atsushi ^a   Bokura, Hirokazu ^a   Yamaguchi, Shuhei ^a   Sugimoto, Toshitsugu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Brain MRI; Cognitive function; Hippocampal atrophy; Type 2 diabetes

Indexed keywords

INSULIN;

ACADEMIC ACHIEVEMENT; AGE; AGED; ARTICLE; BRAIN ATROPHY; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HIPPOCAMPAL ATROPHY; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; REVISED HASEGAWA DEMENTIA SCALE;

AGE FACTORS; AGED; AGING; ASIAN CONTINENTAL ANCESTRY GROUP; ATROPHY; CASE-CONTROL STUDIES; COGNITION; COGNITION DISORDERS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; EDUCATIONAL STATUS; FEMALE; HIPPOCAMPUS; HUMANS; JAPAN; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS;

EID: 81255127489     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.07.002     Document Type: Article

References (26)

1. Leibson C.L., Rocca W.A., Hanson V.A., Cha R., Kokmen E., O'Brien P.C., et al. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 1997, 145:301-308.
2. Allen K.V., Frier B.M., Strachan M.W. The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol 2004, 490:169-175.
3. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., Breteler M.M. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 1999, 53:1937-1942.
4. Yoshitake T., Kiyohara Y., Kato I., Ohmura T., Iwamoto H., Nakayama K., et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995, 45:1161-1168.
5. Luchsinger J.A., Reitz C., Honig L.S., Tang M.X., Shea S., Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 2005, 65:545-551.
6. Jongen C., van der Grond J., Kappelle L.J., Biessels G.J., Viergever M.A., Pluim J.P. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia 2007, 50:1509-1516.
7. Schmidt R., Launer L.J., Nilsson L.G., Pajak A., Sans S., Berger K., et al. Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 2004, 53:687-692.
8. Ohnishi T., Matsuda H., Tabira T., Asada T., Uno M. Changes in brain morphology in Alzheimer disease and normal aging: is Alzheimer disease an exaggerated aging process?. Am J Neuroradiol 2001, 22:1680-1685.
9. Hirata Y., Matsuda H., Nemoto K., Ohnishi T., Hirao K., Yamashita F., et al. Voxel-based morphometry to discriminate early Alzheimer's disease from controls. Neurosci Lett 2005, 382:269-274.
10. The Committee of Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc 2010, 53:450-467.
11. Gispen W.H., Biessels G.J. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 2000, 23:542-549.
12. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001, 357:169-175.
13. Gosche K.M., Mortimer J.A., Smith C.D., Markesbery W.R., Snowdon D.A. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology 2002, 58:1476-1482.
14. den Heijer T., Vermeer S.E., van Dijk E.J., Prins N.D., Koudstaal P.J., Hofman A., et al. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 2003, 46:1604-1610.
15. Korf E.S., van Straaten E.C., de Leeuw F.E., van der Flier W.M., Barkhof F., Pantoni L., et al. Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Diabet Med 2007, 24:166-171.
16. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991, 82:239-259.
17. Bobinski M., de Leon M.J., Wegiel J., Desanti S., Convit A., Saint Louis L.A., et al. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience 2000, 95:721-725.
18. Gold S.M., Dziobek I., Sweat V., Tirsi A., Rogers K., Bruehl H., et al. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 2007, 50:711-719.
19. Gradman T.J., Laws A., Thompson L.W., Reaven G.M. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J Am Geriatr Soc 1993, 41:1305-1312.
20. Schwartz M.W., Sipols A., Kahn S.E., Lattemann D.F., Taborsky G.J., Bergman R.N., et al. Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. Am J Physiol 1990, 259:E378-E383.
21. Park C.R. Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev 2001, 25:311-323.
22. Qiu W.Q., Walsh D.M., Ye Z., Vekrellis K., Zhang J., Podlisny M.B., et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 1998, 273:32730-32738.
23. Vekrellis K., Ye Z., Qiu W.Q., Walsh D., Hartley D., Chesneau V., et al. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 2000, 20:1657-1665.
24. Watson G.S., Peskind E.R., Asthana S., Purganan K., Wait C., Chapman D., et al. Insulin increases CSF Abeta42 levels in normal older adults. Neurology 2003, 60:1899-1903.
25. Luchsinger J.A., Tang M.X., Shea S., Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004, 63:1187-1192.
26. Peila R., Rodriguez B.L., White L.R., Launer L.J. Fasting insulin and incident dementia in an elderly population of Japanese-American men. Neurology 2004, 63:228-233.